wegovy women outcomes

Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congre

Wegovy vs Tirzepatide Obesity Treatment Battle

Wegovy vs Tirzepatide Obesity Treatment Battle In the battle between Wegovy and tirzepatide for obesity treatment, Wegovy achieved an 18% thigh-fat reduction in women versus 12% with tirzepatide, while tirzepatide led overall weight loss. Recent European Congress data also reveal that women on Wegovy lose a larger proportion of body